BehindMLM
first reviewed Immunotec
in 2013.
As per reader request we queued Immunotec for a review update back in February.
Today we’re revisiting Immunotec for an updated review to see what’s changed.
The Company
Immunotec launched in 1996 with a range of glutathione focused nutritional supplements.
Circa 2013 the company was headed up by CEO Charles L. Orr, aka Charlie Orr.
In 2017 Immunotec was partially sold off to Immuno Holding, a Mexican asset manager run by Mauricio Domenzain in partnership with Nexxus Capital.
If I’m understanding correctly, the Immuno Holding sale came about following two Immunotec founding shareholders
wanting to cash out
.
The agreement reached with Immuno Holding concludes a strategic review process that was initiated by Immunotec in response to the desire expressed by Charles Roberts and Dieter Beer, two of its founding shareholders, to monetize their interests in the Company as part their personal estate planning while ensuring that the new owners possess the resources and experience required to drive the Company’s continued growth in the future.
Mr. Roberts will remain as Chairman Emeritus of Immunotec and Mr. John Molson, who is also a founding shareholder, will continue as a key member of the executive team, helping ensure the continuity of the R&D culture originally established by Dr. Gustavo Bounous and Dr. Patricia Kongshavn.
These founding shareholders, who created Immunotec in 1996, own or control an aggregate of 58.5% of the outstanding Shares.
The Immuno Holding deal saw Immunotec go from a Canadian publicly traded company to private ownership.
The 2017 agreement with Immuno Holding saw Mauricio Domenzain replace Charles Orr as Immunotec’s CEO.
Mauricio Domenzain (right) is reported to have an MLM history prior to Immunotec…
Mr. Domenzain is a former top executive of a prominent global direct selling company, with relevant expertise in the Mexican and US markets and a passion for the network marketing industry.
…but I was unable to verify this. A Google search for “Maurico Domenzain” and “mlm” prior to 2017 returns no relevant results.
Immunotec doesn’t provide a corporate address on its website. On LinkedIn Immunotec represents it is based out of Texas in the US.
Immunotec’s Products
Immunotec market a range of supplements targeting immune support, daily wellness, healthy aging, weight management, sports performance, stress and mood, brain health and sleep and restore.
Immunotec’s products have a focus on glutathione, which the company states
enhances your immune system, is a key detoxification enzyme, provides cellular energy and acts as your body’s master antioxidant.
Immunotec’s flagship product is Immunocal, which comes in a number of varieties:
Immunocal – “an all-natural protein with the highest biological value of any edible protein, and clinically proven to raise glutathione levels”, retails at $112 for a box of 30 single-serve pouches
Immunocal Platinum – “offers a comp
🤖 Quick Answer
What is the history of Immunotec's ownership structure?Immunotec, founded in 1996 as a glutathione-focused nutritional supplements company, underwent significant ownership changes. In 2017, the company was partially sold to Immuno Holding, a Mexican asset management firm led by Mauricio Domenzain in partnership with Nexxus Capital, following founding shareholders' decision to divest their stakes.
Who led Immunotec during its 2013 review period?
During the 2013 review period, Immunotec was headed by CEO Charles L. Orr, commonly known as Charlie Orr. His leadership occurred prior to the company's significant ownership restructuring that took place in 2017 with the Immuno Holding acquisition.
What triggered Immunotec's strategic review process in 2017?
Immunotec initiated a
🔗 Related Articles
- Keep It 100’s Terrence Pounds indicted for C-19 loan fraud
- Lifestyle Marketing Group Review 2.0: Matrix points pyramid
- CVC Funding Review: Stolen FINRA broker name Ponzi
- Viral Compensation Review: Ten-tier 3×2 matrix Ponzi cycler
- Mainston Review: $600 four-tier recruitment scheme